Bovine mastitis is the most common infectious disease in dairy herds and causes important economic losses. Various pathogens can cause the disease, with Staphylococcus aureus being one of the most significant. S. aureus can cause clinical, subclinical, and chronic forms of the disease due to a variety of virulence factors, including protein A, coagulase, toxins, and adhesins. The presence of methicillin-resistant S. aureus strains complicates treatment protocols and raises concerns about antimicrobial resistance. The genetic characterization of these strains, utilizing techniques such as molecular typing by pulsed-field gel electrophoresis (PFGE), reveals the existence of different genetic and virulence profiles, as well as the geographical variations in the distribution of these genotypes. The role of next-generation sequencing (NGS) technologies, functional genomics, and multi-omics approaches in the genetic research of bovine mastitis are highlighted, providing a complete understanding of its genetic basis and opening opportunities for targeted interventions and improved disease control strategies in the dairy industry. This review highlights the importance of understanding the genetic diversity and pathogenic mechanisms of S. aureus in bovine mastitis to develop effective disease management strategies and reduce economic losses in the dairy sector globally.
Bovine mastitis is an inflammatory disease of the mammary gland with majoreconomic, sanitary and welfare implications in dairy production. It is caused mainly bybacterial pathogens such as Staphylococcus aureus, Streptococcus agalactiae,Streptococcus uberis and Escherichia coli, which differ in their epidemiology,virulence mechanisms and antimicrobial resistance profiles. This article presents acomparative analysis of the principal etiological agents of bovine mastitis, highlightingtheir prevalence, transmission patterns and capacity to persist within the mammarygland through mechanisms such as biofilm formation and immune evasion. Specialattention is given to the increasing problem of antimicrobial resistance and its impacton treatment efficacy. In addition, recent advances in molecular diagnostics,biotechnological tools and alternative therapeutic strategies are discussed as keycomponents for improving mastitis control, animal welfare and sustainable dairyproduction within a One Health framework.